Aethlon Medical Inc $AEMD
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
This page is still filling in. We publish more sections as filings are processed.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- San Diego, CA
- Fiscal year end
- March 31
- Shares outstanding
- 711,136 [10-Q 2026-08-13]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 3 months to Jun 2026 | — | −$1.55M | −$1.90M | $4.93M | [10-Q 2026-08-13] |
| FY ended Mar 2026 | — | −$7.15M | −$7.00M | $5.03M | [DEF 14A 2026-09-01] |
| FY ended Mar 2025 | — | −$13.40M | −$7.65M | $5.50M | [DEF 14A 2026-09-01] |
- Quarterly cash burn
- −$1.90M
- Cash runway Estimate
- ~7.8 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-06 | 13,961,998 | [10-Q 2024-11-13] |
| 2025-02-10 | 14,457,096 | [10-Q 2025-02-12] |
| 2025-06-24 | 2,585,316 | [10-K 2025-06-26] |
| 2025-08-13 | 2,598,711 | [10-Q 2025-08-13] |
| 2025-11-10 | 761,318 | [10-Q 2025-11-12] |
| 2026-02-11 | 1,315,110 | [10-Q 2026-02-12] |
| 2026-06-08 | 2,370,560 | [10-K 2026-06-10] |
| 2026-08-10 | 711,136 | [10-Q 2026-08-13] |
- Shelf registration
- S-1 filed 2026-06-22; declared effective 2026-07-06 [S-1 2026-06-22]
Listing status
Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-10-22. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2025-10-22 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-10-22] |
| 2025-01-08 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-01-08] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | Shah Chetan | other | 2,182 | $0.82 | [4 2026-07-01] |
| 2026-06-30 | Gikakis Nicolas | other | 2,182 | $0.82 | [4 2026-07-01] |
| 2026-06-30 | Broenniman Edward G | other | 1,091 | $0.82 | [4 2026-07-01] |
| 2026-04-17 | Rossetti Angela | grant | 21,815 | $2.29 | [4 2026-04-21] |
| 2026-04-17 | Shah Chetan | grant | 21,815 | $2.29 | [4 2026-04-21] |
| 2026-04-17 | Broenniman Edward G | grant | 21,815 | $2.29 | [4 2026-04-21] |
| 2026-04-17 | Gikakis Nicolas | grant | 21,815 | $2.29 | [4 2026-04-21] |
| 2026-03-31 | Shah Chetan | other | 178 | $2.19 | [4 2026-04-01] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-09 | 8-K | Charter, bylaws or fiscal year change |
| 2026-10-05 | 8-K | Shareholder vote results |
| 2026-10-01 | 8-K | Director or officer change; Shareholder vote results |
| 2026-09-17 | 8-K | Material agreement entered; Change in control; Regulation FD disclosure |
| 2026-09-15 | 8-K | Director or officer change |
| 2026-09-01 | DEF 14A | Proxy statement |
| 2026-08-31 | 8-K | Other events |
| 2026-08-21 | PRE 14A | Proxy statement |
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-13 | 8-K | Results of operations; Regulation FD disclosure |
| 2026-08-13 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-07-31 | 8-K | Change to security holder rights; Charter, bylaws or fiscal year change |
Alerts for $AEMD
Email me when Aethlon Medical Inc files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.